TY - BOOK PY - 2020 DA - 2020// TI - Universal health coverage (UHC) ID - ref1 ER - TY - JOUR AU - Hogan, D. R. AU - Stevens, G. A. AU - Hosseinpoor, A. R. AU - Boerma, T. PY - 2018 DA - 2018// TI - Monitoring universal health coverage within the Sustainable Development Goals: development and baseline data for an index of essential health services JO - Lancet Glob Health. VL - 6 ID - Hogan2018 ER - TY - BOOK PY - 2020 DA - 2020// TI - Global indicator framework for the Sustainable Development Goals and targets of the 2030 Agenda for Sustainable Development ID - ref3 ER - TY - BOOK PY - 2012 DA - 2012// TI - MDS-3: Managing access to medicines and health technologies ID - ref4 ER - TY - BOOK PY - 2012 DA - 2012// TI - Local production for access to medical products: developing a framework to improve public health PB - OMS, World Health Organization CY - Genève (Suisse) ID - ref5 ER - TY - JOUR AU - Wirtz, V. J. AU - Hogerzeil, H. V. AU - Gray, A. L. AU - Bigdeli, M. AU - Joncheere, C. P. AU - Ewen, M. A. PY - 2017 DA - 2017// TI - Essential medicines for universal health coverage JO - Lancet. VL - 389 ID - Wirtz2017 ER - TY - BOOK PY - 2017 DA - 2017// TI - WHO Global Surveillance and Moonitoring System for Substandard and Falsified Medical Products ID - ref7 ER - TY - STD TI - Sprenger M. Global Action Plan on Antimicrobial Resistance: DRIVE AB Presentation - Setting the Scene. [cited 2020 Feb 4]. Available from: http://drive-ab.eu/wp-content/uploads/2017/09/Marc-Sprenger_Global-AMR-PDF-Protected.pdf. UR - http://drive-ab.eu/wp-content/uploads/2017/09/Marc-Sprenger_Global-AMR-PDF-Protected.pdf ID - ref8 ER - TY - JOUR AU - Weinstein, Z. B. AU - Zaman, M. H. PY - 2018 DA - 2018// TI - Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs JO - Antimicrob Agents Chemother VL - 63 UR - https://doi.org/10.1128/AAC.01243-18 DO - 10.1128/AAC.01243-18 ID - Weinstein2018 ER - TY - JOUR AU - Nwokike, J. AU - Clark, A. AU - Nguyen, P. P. PY - 2018 DA - 2018// TI - Medicines quality assurance to fight antimicrobial resistance JO - Bull World Health Org VL - 96 ID - Nwokike2018 ER - TY - JOUR AU - Mackey, T. K. AU - Liang, B. A. AU - York, P. AU - Kubic, T. PY - 2015 DA - 2015// TI - Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment JO - Am J Trop Med Hyg. VL - 92 ID - Mackey2015 ER - TY - STD TI - Hall A, Antonopoulos G. Fake Meds Online: The Internet and the Transnational Market in Illicit Pharmaceuticals: Palgrave Macmillan Ltd; 2016. [cited 2020 Feb 4]. Available from: https://research.tees.ac.uk/en/publications/fake-meds-online-the-internet-and-the-transnational-market-in-ill-3. UR - https://research.tees.ac.uk/en/publications/fake-meds-online-the-internet-and-the-transnational-market-in-ill-3 ID - ref12 ER - TY - JOUR AU - Jack, A. PY - 2016 DA - 2016// TI - Can anyone stop the illegal sale of medicines online? JO - BMJ. VL - 352 ID - Jack2016 ER - TY - STD TI - Kaiser Health News. Purveyors of Black-Market Pharmaceuticals Target Immigrants. US News & World Report. [cited 2020 Feb 4]. Available from: https://www.usnews.com/news/healthiest-communities/articles/2019-09-16/purveyors-of-black-market-pharmaceuticals-target-immigrants. UR - https://www.usnews.com/news/healthiest-communities/articles/2019-09-16/purveyors-of-black-market-pharmaceuticals-target-immigrants ID - ref14 ER - TY - STD TI - WHO. A study on the public health and socioeconomic impact of substandard and falsified medical products. WHO. [cited 2020 Feb 4]. Available from: http://www.who.int/medicines/regulation/ssffc/publications/se-study-sf/en/. UR - http://www.who.int/medicines/regulation/ssffc/publications/se-study-sf/en/ ID - ref15 ER - TY - STD TI - Ozawa S, Pribluda V, Yemeke TT, Higgins CR, Hajjou M, Evans III L, et al. Integrating medicines quality assurance into Universal Healthcare programming. USP PQM; 2019. [cited 2020 Feb 4]. Available from: https://www.usp-pqm.org/sites/default/files/field/image/pqm-uhc-white-paper.pdf. UR - https://www.usp-pqm.org/sites/default/files/field/image/pqm-uhc-white-paper.pdf ID - ref16 ER - TY - JOUR AU - Renschler, J. P. AU - Walters, K. M. AU - Newton, P. N. AU - Laxminarayan, R. PY - 2015 DA - 2015// TI - Estimated under-five deaths associated with poor-quality antimalarials in sub-Saharan Africa JO - Am J Trop Med Hyg. VL - 92 ID - Renschler2015 ER - TY - JOUR AU - Ozawa, S. AU - Evans, D. R. AU - Bessias, S. AU - Haynie, D. G. AU - Yemeke, T. T. AU - Laing, S. K. PY - 2018 DA - 2018// TI - Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis JO - JAMA Netw Open. VL - 1 ID - Ozawa2018 ER - TY - BOOK PY - 2018 DA - 2018// TI - Crossing the Global Quality Chasm: Improving Health Care Worldwide PB - The National Academies Press CY - Washington, DC ID - ref19 ER - TY - JOUR AU - Beargie, S. M. AU - Higgins, C. R. AU - Evans, D. R. AU - Laing, S. K. AU - Erim, D. AU - Ozawa, S. PY - 2019 DA - 2019// TI - The economic impact of substandard and falsified antimalarial medications in Nigeria JO - PLoS One. VL - 14 ID - Beargie2019 ER - TY - JOUR AU - Ozawa, S. AU - Haynie, D. G. AU - Bessias, S. AU - Laing, S. K. AU - Ngamasana, E. L. AU - Yemeke, T. T. PY - 2019 DA - 2019// TI - Modeling the Economic Impact of Substandard and Falsified Antimalarials in the Democratic Republic of the Congo JO - Am J Trop Med Hyg VL - 100 ID - Ozawa2019 ER - TY - JOUR AU - Ozawa, S. AU - Evans, D. R. AU - Higgins, C. R. AU - Laing, S. K. AU - Awor, P. PY - 2019 DA - 2019// TI - Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study JO - Malar J. VL - 18 ID - Ozawa2019 ER - TY - STD TI - Ledy NM. DRC: $ 5.9 billion budget for 2019. Available from: https://www.kapitalafrik.com/2018/10/12/drc-5-9-billion-budget-for-2019/. [cited 2020 Apr 22]. UR - https://www.kapitalafrik.com/2018/10/12/drc-5-9-billion-budget-for-2019/ ID - ref23 ER - TY - JOUR AU - Emmanuel, K. I. PY - 2016 DA - 2016// TI - The Access to health care in the Democratic Republic of Congo: Major challenge for the poor JO - J Nurs Palliat Care Serv (NPCS) VL - 1 ID - Emmanuel2016 ER - TY - BOOK PY - 2019 DA - 2019// TI - Nigeria Health Facility Registry ID - ref25 ER - TY - STD TI - Ministry of Health, Republic of Uganda. Hospitals | Ministry of Health [Internet]. [cited 2020 Feb 4]. Available from: https://health.go.ug/hospitals. UR - https://health.go.ug/hospitals ID - ref26 ER - TY - JOUR AU - Bertone, M. P. AU - Lurton, G. AU - Mutombo, P. B. PY - 2016 DA - 2016// TI - Investigating the remuneration of health workers in the DR Congo: implications for the health workforce and the health system in a fragile setting JO - Health Policy Plan. VL - 31 ID - Bertone2016 ER - TY - JOUR AU - Obua, T. O. AU - Adome, R. O. AU - Kutyabami, P. AU - Kitutu, F. E. AU - Kamba, P. F. PY - 2017 DA - 2017// TI - Factors associated with occupancy of pharmacist positions in public sector hospitals in Uganda: a cross-sectional study JO - Hum Resour Health. VL - 15 ID - Obua2017 ER - TY - JOUR AU - Ubaka, C. M. AU - Ochie, U. M. AU - Adibe, M. O. PY - 2013 DA - 2013// TI - Student pharmacists’ career choices: a survey of three Nigerian schools of pharmacy JO - Pharm Pract (Granada). VL - 11 ID - Ubaka2013 ER - TY - BOOK PY - 2018 DA - 2018// TI - National-Budget-Framework-Paper-FY-2019-20.pdf ID - ref30 ER - TY - STD TI - WHO. WHO | Guidelines for the development of measures to combat counterfeit medicines: WHO; 1999. [cited 2020 Feb 4]. Available from: http://www.who.int/medicines/publications/counterfeitguidelines/en/. UR - http://www.who.int/medicines/publications/counterfeitguidelines/en/ ID - ref31 ER - TY - BOOK PY - 2013 DA - 2013// TI - Countering the Problem of Falsified and Substandard Drugs PB - The National Academies Press CY - Washington, DC ID - ref32 ER - TY - JOUR AU - Ubajaka, C. AU - Obi-Okaro, A. AU - Emelumadu, O. AU - Azumarah, M. AU - Ukegbu, A. AU - Ilikannu, S. PY - 2016 DA - 2016// TI - Factors Associated with Drug Counterfeit in Nigeria: A Twelve Year Review JO - BJMMR. VL - 12 ID - Ubajaka2016 ER - TY - JOUR AU - Amadi, C. AU - Tsui, E. K. PY - 2019 DA - 2019// TI - How the quality of essential medicines is perceived and maintained through the pharmaceutical supply chain: A perspective from stakeholders in Nigeria JO - Res Soc Adm Pharm VL - 15 ID - Amadi2019 ER - TY - STD TI - Glass B. Counterfeit drugs and medical devices in developing countries. Res Rep Trop Med. 2014;11. ID - ref35 ER - TY - BOOK AU - Christian, L. AU - Collins, L. AU - Kiatgrajai, M. AU - Merle, A. AU - Mukherji, N. AU - Quade, A. PY - 2012 DA - 2012// TI - The Problem of Substandard Medicines in Developing Countries ID - Christian2012 ER - TY - BOOK PY - 2013 DA - 2013// TI - Issue of the extent of fake drugs ID - ref37 ER - TY - JOUR AU - Pisani, E. PY - 2019 DA - 2019// TI - How moves towards universal health coverage could encourage poor quality drugs: an essay by Elizabeth Pisani JO - BMJ. VL - 366 ID - Pisani2019 ER - TY - STD TI - WHO. Tanzania is first African country to reach an important milestone in the regulation of medicines: WHO | Regional Office for Africa; 2018. [cited 2020 Feb 4]. Available from: https://www.afro.who.int/news/tanzania-first-african-country-reach-important-milestone-regulation-medicines. UR - https://www.afro.who.int/news/tanzania-first-african-country-reach-important-milestone-regulation-medicines ID - ref39 ER - TY - BOOK PY - 2020 DA - 2020// TI - Policy: Evaluating and publicly designating regulatory authorities as WHO listed authorities: Draft for comments ID - ref40 ER - TY - JOUR AU - Beyeler, N. AU - Liu, J. AU - Sieverding, M. PY - 2015 DA - 2015// TI - A Systematic Review of the Role of Proprietary and Patent Medicine Vendors in Healthcare Provision in Nigeria JO - PLOS ONE. VL - 10 ID - Beyeler2015 ER - TY - JOUR AU - Buchner, D. L. AU - Kitutu, F. E. AU - Cross, D. E. AU - Nakamoga, E. AU - Awor, P. PY - 2019 DA - 2019// TI - A cross-sectional study to identify the distribution and characteristics of licensed and unlicensed private drug shops in rural Eastern Uganda to inform an iCCM intervention to improve health outcomes for children under five years JO - PLOS ONE. VL - 14 ID - Buchner2019 ER - TY - JOUR AU - Peters, D. H. AU - Bloom, G. PY - 2012 DA - 2012// TI - Developing world: Bring order to unregulated health markets JO - Nature. VL - 487 ID - Peters2012 ER - TY - STD TI - Nigeria has low drugs manufacturing capacity - NAFDAC DG. Vanguard News. 2013 [cited 2020 Feb 4]. Available from: https://www.vanguardngr.com/2013/07/nigeria-has-low-drugs-manufacturing-capacity-nafdac-dg/. UR - https://www.vanguardngr.com/2013/07/nigeria-has-low-drugs-manufacturing-capacity-nafdac-dg/ ID - ref44 ER - TY - JOUR AU - Pisani, E. AU - Nistor, A. -. L. AU - Hasnida, A. AU - Parmaksiz, K. AU - Xu, J. AU - Kok, M. O. PY - 2019 DA - 2019// TI - Identifying market risk for substandard and falsified medicines: an analytic framework based on qualitative research in China, Indonesia, Turkey and Romania JO - Wellcome Open Res VL - 4 ID - Pisani2019 ER - TY - BOOK AU - Zaman, M. H. PY - 2018 DA - 2018// TI - Bitter Pills: The Global War on Counterfeit Drugs PB - Oxford University Press CY - New York ID - Zaman2018 ER - TY - JOUR AU - Tauqeer, F. AU - Myhr, K. AU - Gopinathan, U. PY - 2019 DA - 2019// TI - Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study JO - Health Policy Plan. VL - 34 ID - Tauqeer2019 ER - TY - JOUR AU - Khan, B. AU - Godman, B. AU - Babar, A. AU - Hussain, S. AU - Mahmood, S. AU - Aqeel, T. PY - 2016 DA - 2016// TI - Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan: implications for the future JO - GaBI J. VL - 5 ID - Khan2016 ER - TY - BOOK PY - 2020 DA - 2020// TI - Medicines/Finished Pharmaceutical Products | WHO - Prequalification of Medicines Programme ID - ref49 ER - TY - JOUR AU - Rousham, E. K. AU - Islam, M. A. AU - Nahar, P. AU - Lucas, P. J. AU - Naher, N. AU - Ahmed, S. M. PY - 2019 DA - 2019// TI - Pathways of antibiotic use in Bangladesh: qualitative protocol for the PAUSE study JO - BMJ Open. VL - 9 ID - Rousham2019 ER - TY - JOUR AU - Liu, J. AU - Prach, L. M. AU - Treleaven, E. AU - Hansen, M. AU - Anyanti, J. AU - Jagha, T. PY - 2016 DA - 2016// TI - The role of drug vendors in improving basic health-care services in Nigeria JO - Bull World Health Organ. VL - 94 ID - Liu2016 ER - TY - JOUR AU - Medina, E. AU - Bel, E. AU - Suñé, J. M. PY - 2016 DA - 2016// TI - Counterfeit medicines in Peru: a retrospective review (1997–2014) JO - BMJ Open. VL - 6 ID - Medina2016 ER - TY - BOOK PY - 2011 DA - 2011// TI - Pharmaceutical Sector Profile: Nigeria ID - ref53 ER - TY - JOUR AU - Yadav, P. PY - 2015 DA - 2015// TI - Health Product Supply Chains in Developing Countries: Diagnosis of the Root Causes of Underperformance and an Agenda for Reform JO - Health Syst Reform. VL - 1 ID - Yadav2015 ER - TY - BOOK AU - Pisa, M. AU - McCurdy, D. PY - 2019 DA - 2019// TI - Improving Global Health Supply Chains through Traceability ID - Pisa2019 ER - TY - JOUR AU - Berendes, S. AU - Adeyemi, O. AU - Oladele, E. A. AU - Oresanya, O. B. AU - Okoh, F. AU - Valadez, J. J. PY - 2012 DA - 2012// TI - Are Patent Medicine Vendors Effective Agents in Malaria Control? Using Lot Quality Assurance Sampling to Assess Quality of Practice in Jigawa, Nigeria JO - PLOS ONE VL - 7 ID - Berendes2012 ER - TY - BOOK PY - 2017 DA - 2017// TI - Combating substandard and falsified medicines ID - ref57 ER - TY - JOUR AU - Aminu, N. AU - Sha’aban, A. AU - Abubakar, A. AU - Gwarzo, M. S. PY - 2017 DA - 2017// TI - Unveiling the Peril of Substandard and Falsified Medicines to Public Health and Safety in Africa: Need for All-Out War to End the Menace JO - Med Access Point Care VL - 1 ID - Aminu2017 ER - TY - JOUR AU - Lamy, M. AU - Liverani, M. PY - 2015 DA - 2015// TI - Tackling Substandard and Falsified Medicines in the Mekong: National Responses and Regional Prospects: Substandard Medicines in the Mekong JO - Asia Pac Policy Stud. VL - 2 ID - Lamy2015 ER - TY - JOUR AU - Hamilton, W. L. AU - Doyle, C. AU - Halliwell-Ewen, M. AU - Lambert, G. PY - 2016 DA - 2016// TI - Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies JO - Health Policy Plan VL - 31 ID - Hamilton2016 ER - TY - JOUR AU - Attaran, A. PY - 2015 DA - 2015// TI - Stopping Murder by Medicine: Introducing the Model Law on Medicine Crime JO - Am J Trop Med Hyg VL - 92 ID - Attaran2015 ER - TY - STD TI - Shaon AI. Fake drug factory busted in Dhaka: Dhaka Tribune; 2014. [cited 2020 Feb 4]. Available from: https://www.dhakatribune.com/uncategorized/2014/12/08/fake-drug-factory-busted-in-dhaka. UR - https://www.dhakatribune.com/uncategorized/2014/12/08/fake-drug-factory-busted-in-dhaka ID - ref62 ER - TY - JOUR AU - Sylim, P. AU - Liu, F. AU - Marcelo, A. AU - Fontelo, P. PY - 2018 DA - 2018// TI - Blockchain Technology for Detecting Falsified and Substandard Drugs in Distribution: Pharmaceutical Supply Chain Intervention JO - JMIR Res Protoc. VL - 7 ID - Sylim2018 ER - TY - JOUR AU - Akinyandenu, O. PY - 2013 DA - 2013// TI - Counterfeit drugs in Nigeria: A threat to public health JO - Afr J Pharm Pharmacol. VL - 7 ID - Akinyandenu2013 ER - TY - JOUR AU - Akunyili, D. PY - 2004 DA - 2004// TI - Fake and counterfeit drugs in the health sector: The role of medical doctors JO - Ann Ibadan Postgrad Med VL - 2 ID - Akunyili2004 ER - TY - STD TI - Webb S. A bitter pill to swallow: the problem of, and solutions to, Sub-Saharan Africa’s counterfeit pharmaceutical trade. J Glob Health. 2014; [cited 2020 Feb 4]; Available from: www.ghjournal.org/a-bitter-pill-to-swallow-the-problem-of-and-solutions-to-sub-saharan-africas-counterfeit-pharmaceutical-trade/. UR - http://www.ghjournal.org/a-bitter-pill-to-swallow-the-problem-of-and-solutions-to-sub-saharan-africas-counterfeit-pharmaceutical-trade/ ID - ref66 ER - TY - JOUR AU - Jacobs, T. G. AU - Robertson, J. AU - Ham, H. A. AU - Iwamoto, K. AU - Bak Pedersen, H. AU - Mantel-Teeuwisse, A. K. PY - 2019 DA - 2019// TI - Assessing the impact of law enforcement to reduce over-the-counter (OTC) sales of antibiotics in low- and middle-income countries; a systematic literature review JO - BMC Health Serv Res. VL - 19 ID - Jacobs2019 ER - TY - JOUR AU - Alrasheedy, A. A. AU - Alsalloum, M. A. AU - Almuqbil, F. A. AU - Almuzaini, M. A. AU - Aba Alkhayl, B. S. AU - Albishri, A. S. PY - 2020 DA - 2020// TI - The impact of law enforcement on dispensing antibiotics without prescription: a multi-methods study from Saudi Arabia JO - Expert Rev Anti Infect Ther. VL - 18 ID - Alrasheedy2020 ER - TY - STD TI - Cartwright R, Baric A. The rise of counterfeit pharmaceuticals in Africa. 16. ID - ref69 ER - TY - JOUR AU - Fadlallah, R. AU - El-Jardali, F. AU - Annan, F. AU - Azzam, H. AU - Akl, E. A. PY - 2016 DA - 2016// TI - Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness JO - Pharm Med. VL - 30 ID - Fadlallah2016 ER - TY - JOUR AU - Nayyar, G. M. L. AU - Attaran, A. AU - Clark, J. P. AU - Culzoni, M. J. AU - Fernandez, F. M. AU - Herrington, J. E. PY - 2015 DA - 2015// TI - Responding to the Pandemic of Falsified Medicines JO - Am J Trop Med Hyg VL - 92 ID - Nayyar2015 ER - TY - JOUR AU - Roth, L. AU - Bempong, D. AU - Babigumira, J. B. AU - Banoo, S. AU - Cooke, E. AU - Jeffreys, D. PY - 2018 DA - 2018// TI - Expanding global access to essential medicines: investment priorities for sustainably strengthening medical product regulatory systems JO - Glob Health. VL - 14 ID - Roth2018 ER - TY - JOUR AU - Vickers, S. AU - Bernier, M. AU - Zambrzycki, S. AU - Fernandez, F. M. AU - Newton, P. N. AU - Caillet, C. PY - 2018 DA - 2018// TI - Field detection devices for screening the quality of medicines: a systematic review JO - BMJ Glob Health. VL - 3 ID - Vickers2018 ER - TY - BOOK AU - Roth, S. AU - Ball, D. AU - Khetrapal, S. PY - 2018 DA - 2018// TI - Portable Screening Devices for Medicine Quality: Putting Power into the Hands of Regulators in Low-Resource Settings ID - Roth2018 ER - TY - BOOK AU - Vorrath, J. AU - Voss, M. PY - 2019 DA - 2019// TI - The Hidden Dangers of Falsified and Substandard Medicines. Developing Countries Are Most Affected by the Illegal Trade ID - Vorrath2019 ER - TY - JOUR AU - Fadlallah, R. AU - El-Jardali, F. AU - Hemadi, N. AU - Morsi, R. Z. AU - Abou Samra, C. A. AU - Ahmad, A. PY - 2018 DA - 2018// TI - Barriers and facilitators to implementation, uptake and sustainability of community-based health insurance schemes in low- and middle-income countries: a systematic review JO - Int J Equity Health VL - 17 ID - Fadlallah2018 ER - TY - JOUR AU - Faden, L. AU - Vialle-Valentin, C. AU - Ross-Degnan, D. AU - Wagner, A. PY - 2011 DA - 2011// TI - Active pharmaceutical management strategies of health insurance systems to improve cost-effective use of medicines in low- and middle-income countries: A systematic review of current evidence JO - Health Policy. VL - 100 ID - Faden2011 ER - TY - JOUR AU - Wagner, A. K. AU - Graves, A. J. AU - Reiss, S. K. AU - Lecates, R. AU - Zhang, F. AU - Ross-Degnan, D. PY - 2011 DA - 2011// TI - Access to care and medicines, burden of health care expenditures, and risk protection: results from the World Health Survey JO - Health Policy. VL - 100 ID - Wagner2011 ER - TY - JOUR AU - Dalinjong, P. A. AU - Welaga, P. AU - Akazili, J. AU - Kwarteng, A. AU - Bangha, M. AU - Oduro, A. PY - 2017 DA - 2017// TI - The association between health insurance status and utilization of health services in rural Northern Ghana: evidence from the introduction of the National Health Insurance Scheme JO - J Health Popul Nutr VL - 36 ID - Dalinjong2017 ER - TY - JOUR AU - Gnawali, D. P. AU - Pokhrel, S. AU - Sié, A. AU - Sanon, M. AU - Allegri, M. AU - Souares, A. PY - 2009 DA - 2009// TI - The effect of community-based health insurance on the utilization of modern health care services: Evidence from Burkina Faso JO - Health Policy. VL - 90 ID - Gnawali2009 ER - TY - JOUR AU - Spaan, E. AU - Mathijssen, J. AU - Tromp, N. AU - McBain, F. AU - Have, A. AU - Baltussen, R. PY - 2012 DA - 2012// TI - The impact of health insurance in Africa and Asia: a systematic review JO - Bull World Health Org. VL - 90 ID - Spaan2012 ER - TY - JOUR AU - Rutta, E. AU - Liana, J. AU - Embrey, M. PY - 2015 DA - 2015// TI - Accrediting retail drug shops to strengthen Tanzania's public health system: an ADDO case study [published correction appears in J Pharm Policy Pract. 2015;8:29] JO - J Pharm Policy Pract VL - 8 UR - https://doi.org/10.1186/s40545-015-0044-4 DO - 10.1186/s40545-015-0044-4 ID - Rutta2015 ER - TY - BOOK PY - 2016 DA - 2016// TI - Bangladesh to introduce ‘model pharmacy’ to stop fake drug sales ID - ref83 ER - TY - JOUR AU - Embrey, M. AU - Vialle-Valentin, C. AU - Dillip, A. AU - Kihiyo, B. AU - Mbwasi, R. AU - Semali, I. A. PY - 2016 DA - 2016// TI - Understanding the Role of Accredited Drug Dispensing Outlets in Tanzania’s Health System. Marsh V, editor JO - PLoS ONE VL - 11 ID - Embrey2016 ER - TY - JOUR AU - Mwita, S. AU - Jande, M. AU - Marwa, K. AU - Hamasaki, K. AU - Katabalo, D. AU - Burger, J. PY - 2017 DA - 2017// TI - Medicines dispensers’ knowledge on the implementation of an artemisinin-based combination therapy policy for the treatment of uncomplicated malaria in Tanzania JO - J Pharm Health Serv Res. VL - 8 ID - Mwita2017 ER - TY - JOUR AU - Mukokinya, M. A. AU - Opanga, S. AU - Oluka, M. AU - Godman, B. PY - 2018 DA - 2018// TI - Dispensing of antimicrobials in Kenya: A cross-sectional pilot study and its implications JO - J Res Pharm Pract. VL - 7 ID - Mukokinya2018 ER - TY - BOOK AU - Ibrahim, A. PY - 2016 DA - 2016// TI - Pharmacovigilance-Newsletter_Vol-9.pdf ID - Ibrahim2016 ER - TY - JOUR AU - Binagwaho, A. AU - Bate, R. AU - Gasana, M. AU - Karema, C. AU - Mucyo, Y. AU - Mwesigye, J. P. PY - 2013 DA - 2013// TI - Combatting substandard and falsified medicines: a view from Rwanda JO - PLoS Med. VL - 10 ID - Binagwaho2013 ER - TY - BOOK AU - Silverman, R. AU - Keller, J. M. AU - Glassman, A. AU - Chalkidou, K. PY - 2019 DA - 2019// TI - Tackling the Triple Transition in Global Health Procurement ID - Silverman2019 ER - TY - BOOK PY - 2020 DA - 2020// TI - Falsified Medicines Directive (FMD) | ABPI ID - ref90 ER - TY - STD TI - Robinson J, Editor S. Falsified Medicines Directive (FMD): how it will work. Pharma J. 2018. [cited 2020 Feb 4]. Available from: https://www.pharmaceutical-journal.com/news-and-analysis/infographics/falsified-medicines-directive-fmd-how-it-will-work/20204433.article. UR - https://www.pharmaceutical-journal.com/news-and-analysis/infographics/falsified-medicines-directive-fmd-how-it-will-work/20204433.article ID - ref91 ER - TY - STD TI - Barojas A. The Three-Level Approach: A Framework for Ensuring Medicines Quality in Limited-Resource Countries. Pharmaceut Reg Affairs. 2014;03(01) [cited 2019 Oct 4]; Available from: http://www.omicsgroup.org/journals/the-threelevel-approach-a-framework-for-ensuring-medicines-quality-in-limitedresource-countries-2167-7689.1000117.php?aid=24068. UR - http://www.omicsgroup.org/journals/the-threelevel-approach-a-framework-for-ensuring-medicines-quality-in-limitedresource-countries-2167-7689.1000117.php?aid=24068 ID - ref92 ER - TY - BOOK PY - 2016 DA - 2016// TI - WHO Expert Committee on Specifications for Pharmaceutical Preparations: fiftieth report PB - WHO CY - Geneva ID - ref93 ER - TY - STD TI - Ecumenical Pharmaceutical Network. Assuring the Quality of Medicines. [cited 2020 Feb 4]. Available from: https://apps.who.int/medicinedocs/fr/m/abstract/Js19964en/. UR - https://apps.who.int/medicinedocs/fr/m/abstract/Js19964en/ ID - ref94 ER - TY - JOUR AU - Petersen, A. AU - Held, N. AU - Heide, L. PY - 2017 DA - 2017// TI - Surveillance for falsified and substandard medicines in Africa and Asia by local organizations using the low-cost GPHF Minilab JO - PLOS ONE VL - 12 ID - Petersen2017 ER - TY - STD TI - Kusumewera D. Health Action International: Mission-Sector. [cited 2020 Feb 4]. Available from: https://haiweb.org/wp-content/uploads/2019/12/Mission-Sector.pdf. UR - https://haiweb.org/wp-content/uploads/2019/12/Mission-Sector.pdf ID - ref96 ER - TY - JOUR AU - Rasheed, H. AU - Höllein, L. AU - Holzgrabe, U. PY - 2018 DA - 2018// TI - Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries JO - Front Pharmacol. VL - 9 ID - Rasheed2018 ER - TY - BOOK AU - Makgetla, I. PY - 2009 DA - 2009// TI - Oral history program: Governance Traps, Interview no H1 ID - Makgetla2009 ER - TY - STD TI - Emmen MB. Crowdsourcing the Fight Against Fake Drugs: GAB | The Global Anticorruption Blog; 2014. [cited 2020 Feb 4]. Available from: https://globalanticorruptionblog.com/2014/12/12/crowdsourcing-the-fight-against-fake-drugs/. UR - https://globalanticorruptionblog.com/2014/12/12/crowdsourcing-the-fight-against-fake-drugs/ ID - ref99 ER - TY - BOOK PY - 2020 DA - 2020// TI - WHO welcomes landmark UN declaration on universal health coverage ID - ref100 ER -